Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Health Professional Information [NCI] - Lycopene
OverviewThis section contains the following key information:Lycopene is a carotenoid, a natural pigment made by plants and various fruits and vegetables, including tomatoes, apricot, guava, and watermelon.Lycopene's absorption is improved with concurrent dietary fat intake.Lycopene inhibits androgen receptor expression in prostate cancer cells in vitro and, along with some of its metabolites, reduces prostate cancer cell proliferation and may modulate cell-cycle progression.Lycopene may also affect the insulin-like growth factor intracellular pathway in prostate cancer cells.Results from several in vitro and animal studies have indicated that lycopene may have chemopreventive effects for cancers of the prostate, skin, breast, lung, and liver; however, human trials have been inconsistent in their findings. Clinical trials utilizing lycopene in prostate cancer patients with various different clinical presentations (e.g., early stage, prostate-specific antigen (PSA)
Prostate Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Stages of Prostate Cancer
After prostate cancer has been diagnosed,tests are done to find out if cancer cells have spread within the prostate or to other parts of the body. The process used to find out if cancer has spread within the prostate or to other parts of the body is called staging. The information gathered from the staging process determines the stage of the disease. It is important to know the stage in order .
Prostate Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage Information for Prostate Cancer
Staging TestsMost men are diagnosed with prostate cancer at an early clinical stage and do not have detectable metastases. Therefore, they generally do not have to undergo staging tests, such as a bone scan, computed tomography (CT), or magnetic resonance imaging (MRI). However, staging studies are done if there is clinical suspicion of metastasis, such as bone pain; local tumor spread beyond the prostate capsule; or a substantial risk of metastasis (prostate-specific antigen [PSA] >20 ng/ml and Gleason score >7).Tests used to determine stage include the following:Radionuclide bone scans.Serum PSA level.MRI.Pelvic lymph node dissection (PLND).Transrectal or transperineal biopsy.Transrectal ultrasound (TRUS).CT scans.Radionuclide bone scansA radionuclide bone scan is the most widely used test for metastasis to the bone, which is the most common site of distant
Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - Introduction
Men in the United States get prostate cancer more than any other type of cancer except skin cancer. It is found mainly in older men. In the United States, about one out of five men will be diagnosed with prostate cancer. Most men diagnosed with prostate cancer do not die of it.Complementary and alternative medicine (CAM) is a form of treatment used in addition to (complementary) or instead of (alternative) standard treatments. CAM treatments generally are not considered standard medical approaches. Standard treatments go through a long and careful research process to prove they are safe and effective, but less is known about most types of CAM. CAM use among prostate cancer patients is reported to be common. CAM treatments used by prostate cancer patients include certain foods, dietary supplements, herbs, vitamins, and minerals. This PDQ CAM summary gives general information about using foods and dietary supplements to lower the risk of developing prostate cancer or for treating
Prostate Cancer Prevention (PDQ®): Prevention - Health Professional Information [NCI] - Changes to This Summary (02 / 15 / 2013)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.SignificanceUpdated statistics with estimated new cases and deaths for 2013 (cited American Cancer Society as reference 1).This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.
Prostate Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - nci_ncicdr0000062965-nci-header
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Prostate Cancer Treatment
Prostate Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - General Information About Prostate Cancer
Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate. The prostate is a gland in the male reproductive system located just below the bladder (the organ that collects and empties urine) and in front of the rectum (the lower part of the intestine). It is about the size of a walnut and surrounds part of the urethra (the tube that empties urine from the
Prostate Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - General Information About Prostate Cancer
Carcinoma of the prostate is predominantly a tumor of older men: the median age at diagnosis is 72 years. Prostate cancer may be cured when localized, and it frequently responds to treatment when widespread. The rate of tumor growth varies from very slow to moderately rapid, and some patients may have prolonged survival even after the cancer has metastasized to distant sites, such as bone. The 5-year relative survival rate for men diagnosed in the United States from 2001 to 2007 with local or regional disease was 100%, and the rate for distant disease was 28.7%; a 99% survival rate was observed for all stages combined.[SEER Stat Fact Sheets: Prostate] The approach to treatment is influenced by age and coexisting medical problems. Side effects of various forms of treatment should be considered in selecting appropriate management.Many patients—especially those with localized tumors—may die of other illnesses without ever having suffered disability from the cancer, even
Prostate Cancer Myths and Facts
Prostate cancer is the second most commonly diagnosed cancer in men, but what do you know about it?
Pain Control Record Chart
Using this pain scale from WebMD to measure your feeling of pain.